All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

  1. A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study

    KCE Reports 231 (2014)

    https://kce.fgov.be/en/a-quadrivalent-vaccine-against-serogroup-b-meningococcal-disease-a-cost-effectiveness-study

  2. Anticoagulants in non-valvular atrial fibrillation

    KCE Reports 279 (2016)

    https://kce.fgov.be/en/anticoagulants-in-non-valvular-atrial-fibrillation
  3. Illustration report 298

    MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer

    KCE Report 298 (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy. In theory, this treatment is enough to eradicate the tumour since it is still limited. However, it is known that about 30% of patients treated in this way are at risk of developing remote metastases, because metastatic cancerous cells are already present but undetectable at the time of diagnosis.

    https://kce.fgov.be/en/mammaprint%C2%AE-test-for-personalised-management-of-adjuvant-chemotherapy-decisions-in-early-breast
  4. Defibrillator

    Static automated external defibrillators for opportunistic use by bystanders

    KCE Reports 294 (2017)

    https://kce.fgov.be/en/static-automated-external-defibrillators-for-opportunistic-use-by-bystanders